Smith & Nephew (SNN) Enterprise Value (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Enterprise Value of -$577.0 million for Q4 2025, up 13.36% year-on-year from -$509.0 million in Q4 2024, and up 14.64% on a QoQ basis from -$676.0 million in Q2 2025.
Smith & Nephew (SNN) Enterprise Value (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Enterprise Value for 17 consecutive years, with -$577.0 million the latest figure, recorded in Q4 2025.
- Quarterly Enterprise Value rose 13.36% year-over-year to -$577.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$577.0 million (up 13.36% YoY) and the FY2025 annual result came in at -$577.0 million, up 13.36% from the prior year.
- Enterprise Value rose to -$577.0 million in Q4 2025 per SNN's latest filing, from -$676.0 million in the prior quarter.
- Over the last five years, Enterprise Value for SNN reached as high as -$329.0 million in Q4 2023 and fell as low as -$1.3 billion in Q4 2021.
- A 5-year average of -$648.9 million and a median of -$577.0 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 70.13% — and 2024, when it plunged 102.43%.
- Year by year, Enterprise Value stood at -$1.3 billion in 2021, then jumped by 70.13% to -$397.0 million in 2022, then climbed by 17.13% to -$329.0 million in 2023, then sank by 102.43% to -$666.0 million in 2024, then climbed by 13.36% to -$577.0 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$577.0 million, -$676.0 million, and -$666.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | -426.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -577.00 Mn |
| Jun 28, 2025 | -676.00 Mn |
| Dec 31, 2024 | -666.00 Mn |
| Jun 29, 2024 | -568.00 Mn |
| Dec 31, 2023 | -329.00 Mn |
| Dec 31, 2022 | -397.00 Mn |
| Dec 31, 2021 | -1.33 Bn |
| Dec 31, 2020 | -1.79 Bn |
| Jun 30, 2020 | -347.00 Mn |
| Dec 31, 2019 | -283.00 Mn |
| Jun 29, 2019 | -137.00 Mn |
| Dec 31, 2018 | -370.00 Mn |
| Jun 30, 2018 | -99.00 Mn |
| Dec 31, 2017 | -183.00 Mn |
| Dec 31, 2016 | -86.00 Mn |
| Dec 31, 2015 | -135.00 Mn |
| Jun 30, 2015 | -88.00 Mn |
| Dec 31, 2014 | -65.00 Mn |
| Sep 30, 2014 | -147.00 Mn |
| Jun 28, 2014 | -140.00 Mn |